Friday, October 17, 2014
Reminder Compounding Pharmacies Have Financial Interests in Compounding Drugs!!
Quoted from PPSI - Pharmacy Compounding Facts 
www.ppsinc.org/phcom/13prescriber.htm
Very Good Information! Must Read Illegal Animal Drug Compounding, Your Legal Nightmare Waiting to Happen by Charlotte A. Lacroix DVM, Esq.
Illegal Drug Compounding - American Association of Equine ...
www.aaep.org/.../illegal_drug_compounding.p...
AAEP For Horse Owners
Third Question of the Day October 17, 2014 Read the following from the FBI regarding Criminal Enterprise. How many believe that the compounding industry may have some criminal liability under RICO as a cirminal enterprise? Why? or Why not? Haven't we already seen mail fraud, wire fraud, trafficking in counterfeit goods, money laundering, state and federal charges for murder and drug Is violations? Possible corrupt public officals? And threats against people who try to expose them?
Criminal Enterprise
The FBI defines a criminal enterprise as a group of individuals with an identified hierarchy, or comparable structure,
engaged in significant criminal activity. These organizations often engage in multiple criminal activities and have extensive supporting networks. The terms Organized Crime and Criminal Enterprise are similar and often used synonymously. However, various federal criminal statutes specifically
define the elements of an enterprise that need to be proven in order to convict individuals or groups of individuals under
those statutes.
The Racketeer Influenced and Corrupt Organizations (RICO) statute, or Title 18 of the United States Code, Section 1961(4), defines an enterprise as "any individual, partnership, corporation, association, or other legal entity, and any union or group of individuals associated in fact although
not a legal entity."
The Continuing Criminal Enterprise statute, or Title 21 of the United States Code, Section 848(c)(2), defines a criminal
enterprise as any group of six or more people, where one of the six occupies a position of organizer, a supervisory position, or any other position of management with respect to the other five, and which generates substantial income or resources, and is engaged in a continuing series of violations
of subchapters I and II of Chapter 13 of Title 21 of the United States Code.
Organized Crime
The FBI defines organized crime as any group having some manner of a formalized structure and whose primary
objective is to obtain money through illegal activities. Such groups maintain their position through the use of actual or
threatened violence, corrupt public officials, graft, or extortion, and generally have a significant impact on the people in
their locales, region, or the country as a whole.
Significant Racketeering Activity
The FBI defines significant racketeering activities as those predicate criminal acts that are chargeable under the Racketeer Influenced and Corrupt Organizations statute. These are found in Title 18 of the United States Code, Section 1961 (1) and include the following federal crimes:
And the following state crimes:
|
Second Question of the Day October 17, 2014 What would happen to the compounding pharmacy industry if there was actual full disclosure of the ingredients and the risks, all rules and laws followed and no false or misleading advertising? How fast would the criminal enterprise side of this market dry up?
Oregon Board of Pharmacy to Discuss Establishing a Non-Profit Compounding Pharmacy
Cruel and Unusual
... Oregon Board of Pharmacy to discuss establishing a nonprofitcompounding pharmacy to manufacture a generic form of pentobarbital, which C&C would then ..
Maryland Board of Pharmacy Provides Notice of New Compounding Rules Effective January 1, 2015
NOTICE - DHMH
dhmh.maryland.gov/.../FINAL%20website%20notice%20imple...Maryland17 hours ago - Beginning January 1, 2015, any sterile compounding facility that performs sterile compounding for patient-specific dispensing into, out of, or within Maryland will ...
NEW BANKRUPTCY OPINION: IN RE NEW ENGLAND COMPOUNDING PHARMACY, INC., PRODUCTS LIABILITY LITIGATION – DIST. COURT, D. MASSACHUSETTS, 2014 OCTOBER 16, 2014
N RE: NEW ENGLAND COMPOUNDING PHARMACY, INC., PRODUCTS LIABILITY LITIGATION.
MDL No. 13-02419-RWZ.
United States District Court, D. Massachusetts.
October 9, 2014.
ORDER LIMITING DISCOVERY AND STAYING THESE PROCEEDINGS WITH RESPECT TO NECC INSIDERS AND RELATED SETTLING PARTIES
RYA W. ZOBEL, District Judge.
Paul D. Moore, the Chapter 11 trustee (the “Trustee”) of New England Compounding Pharmacy, Inc. d/b/a New England Compounding Center (“NECC”), has entered into three settlement agreements (the “Settlements”) resolving potential claims against various parties in exchange for, among other things, substantial contributions of assets and cash to the NECC bankruptcy estate. The Settlements have been approved in NECC’s pending Chapter 11 case by the United States Bankruptcy Court for the District of Massachusetts.
continue to read here
Subscribe to:
Posts (Atom)